A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Familial Myeloma | NEJM
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
What are Free Kappa Light Chains, Serum? – HealthMatters.io – Lab results explained
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms
Kappa Light Chain Antibody (L1C1) - Azide and BSA Free (NBP2-33142): Novus Biologicals
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE